{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T16:15:39Z","timestamp":1790784939013,"version":"4.1.0"},"reference-count":24,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T00:00:00Z","timestamp":1765324800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>\n                    Immunoglobulin G4-related disease (IgG4-RD) is a rare, multisystem disorder with diagnostic challenges. We report a case of IgG4-RD initially presenting with acute kidney injury (AKI) and hypercalcemia in a 61-year-old woman with a history of recurrent eyelid edema. On admission, serum creatinine and calcium were significantly elevated (414 \u03bcmol\/L and 3.69 mmol\/L, respectively). After excluding other etiologies, diagnosis was confirmed by renal biopsy and elevated serum IgG4 levels. Treatment with prednisone acetate and supportive care resulted in gradual clinical and laboratory improvement. This case underscores the importance of considering IgG4-RD in patients with unexplained AKI and hypercalcemia, highlighting the value of early diagnosis and targeted therapy. Furthermore, we explored potential pathophysiological mechanisms underlying hypercalcemia in IgG4-RD and found that M2 macrophages may overexpress 1\u03b1-hydroxylase, enhancing the conversion to active 1,25(OH)\n                    <jats:sub>2<\/jats:sub>\n                    D, and thereby increasing intestinal calcium absorption and leading to hypercalcemia, which has also been described in granulomatous diseases.\n                  <\/jats:p>","DOI":"10.3389\/fimmu.2025.1720791","type":"journal-article","created":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T06:36:03Z","timestamp":1765348563000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["IgG4-related disease presenting with hypercalcemia: case report and mechanistic insights"],"prefix":"10.3389","volume":"16","author":[{"given":"Yaxin","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhangxue","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,12,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1038\/s41584-025-01240-x","article-title":"IgG4-related disease and other fibro-inflammatory conditions","volume":"21","author":"Peyronel","year":"2025","journal-title":"Nat Rev Rheumatol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1104650","article-title":"IgG4-related disease","volume":"366","author":"Stone","year":"2012","journal-title":"New Engl J Med"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2018-214603","article-title":"Clinical phenotypes of IgG4-related disease: an analysis of two international cross-sectional cohorts","volume":"78","author":"Wallace","year":"2019","journal-title":"Ann rheumatic diseases"},{"key":"B4","article-title":"Calcium and vitamin D metabolism in sarcoidosis","volume":"30","author":"Baughman","year":"2013","journal-title":"Sarcoidosis vasculitis diffuse Lung Dis"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2020.00497","article-title":"Hypercalcemia, an important puzzle piece in uncommon onset pediatric sarcoidosis-A case report and a review of the literature","volume":"8","author":"M\u0103rginean","year":"2020","journal-title":"Front pediatrics"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1080\/14397595.2020.1859710","article-title":"The 2020 revised comprehensive diagnostic (RCD) criteria for IgG4-RD","volume":"31","author":"Umehara","year":"2021","journal-title":"Modern Rheumatol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1002\/art.41120","article-title":"The 2019 american college of rheumatology\/european league against rheumatism classification criteria for igG4-related disease","volume":"72","author":"Wallace","year":"2020","journal-title":"Arthritis Rheumatol (Hoboken NJ)"},{"key":"B8","doi-asserted-by":"publisher","first-page":"h2723","DOI":"10.1136\/bmj.h2723","article-title":"The diagnosis and management of hypercalcaemia","volume":"350","author":"Minisola","year":"2015","journal-title":"BMJ (Clinical Res ed)"},{"key":"B9","doi-asserted-by":"publisher","first-page":"e14760","DOI":"10.1111\/1756-185X.14760","article-title":"IgG4-related disease presenting as severely symptomatic hypercalcemia: A case report and review of literature","volume":"27","author":"Han","year":"2024","journal-title":"Int J rheumatic diseases"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa040008","article-title":"Acquired hypocalciuric hypercalcemia due to autoantibodies against the calcium-sensing receptor","volume":"351","author":"Pallais","year":"2004","journal-title":"New Engl J Med"},{"key":"B11","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s13730-018-0358-6","article-title":"A case of fatal osteolytic hypercalcemia complicated with IgG4-related ophthalmic disease leading to renal failure","volume":"8","author":"Kawakita","year":"2019","journal-title":"CEN Case Rep"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1007\/s00535-017-1390-6","article-title":"Basophils activated via TLR signaling may contribute to pathophysiology of type 1 autoimmune pancreatitis","volume":"53","author":"Yanagawa","year":"2018","journal-title":"J gastroenterology"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1080\/14397595.2018.1536364","article-title":"Cytokines produced by innate immune cells in IgG4-related disease","volume":"29","author":"Yoshikawa","year":"2019","journal-title":"Modern Rheumatol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1002\/art.33386","article-title":"Involvement of activation of toll-like receptors and nucleotide-binding oligomerization domain-like receptors in enhanced IgG4 responses in autoimmune pancreatitis","volume":"64","author":"Watanabe","year":"2012","journal-title":"Arthritis rheumatism"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keab610","article-title":"Phenotype, function and clinical significance of innate lymphoid cells in immunoglobulin G4-related disease","volume":"61","author":"Zhang","year":"2022","journal-title":"Rheumatol (Oxford England)"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1002\/art.41052","article-title":"Activated M2 macrophages contribute to the pathogenesis of igG4-related disease via toll-like receptor 7\/interleukin-33 signaling","volume":"72","author":"Ishiguro","year":"2020","journal-title":"Arthritis Rheumatol (Hoboken NJ)"},{"key":"B17","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.clim.2014.10.008","article-title":"Preferential M2 macrophages contribute to fibrosis in IgG4-related dacryoadenitis and sialoadenitis, so-called Mikulicz\u2019s disease","volume":"156","author":"Furukawa","year":"2015","journal-title":"Clin Immunol (Orlando Fla)"},{"key":"B18","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1002\/art.42043","article-title":"CD163+ M2 macrophages promote fibrosis in igG4-related disease via toll-like receptor 7\/interleukin-1 receptor-associated kinase 4\/NF-\u03baB signaling","volume":"74","author":"Chinju","year":"2022","journal-title":"Arthritis Rheumatol (Hoboken NJ)"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198108203050807","article-title":"Hypercalcemia in an anephric patient with sarcoidosis: evidence for extrarenal generation of 1,25-dihydroxyvitamin D","volume":"305","author":"Barbour","year":"1981","journal-title":"New Engl J Med"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.722806","article-title":"Macrophages control the bioavailability of vitamin D and vitamin D-regulated T cell responses","volume":"12","author":"Lopez","year":"2021","journal-title":"Front Immunol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3390\/cells12040670","article-title":"Peripheral immunophenotype in igG4-related disease and its association with clinical phenotypes and disease activity","volume":"12","author":"Mart\u00edn-Nares","year":"2023","journal-title":"Cells"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3109\/03009742.2015.1055796","article-title":"IgG4-related disease in Italy: clinical features and outcomes of a large cohort of patients","volume":"45","author":"Campochiaro","year":"2016","journal-title":"Scandinavian J Rheumatol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.ejim.2024.06.006","article-title":"Efficacy and safety of rituximab induction therapy and effect of rituximab maintenance for IgG4-related disease: a systematic review and meta-analysis","volume":"127","author":"Liu","year":"2024","journal-title":"Eur J Internal Med"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kez380","article-title":"Glucocorticoids and steroid sparing medications monotherapies or in combination for IgG4-RD: a systematic review and network meta-analysis","volume":"59","author":"Omar","year":"2020","journal-title":"Rheumatol (Oxford England)"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1720791\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T06:36:04Z","timestamp":1765348564000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1720791\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,10]]},"references-count":24,"alternative-id":["10.3389\/fimmu.2025.1720791"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1720791","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,10]]},"article-number":"1720791"}}